Last Updated on November 26, 2024 by admin
Pharma Packaging Trends for 2025.
In the rapidly evolving landscape of the pharmaceutical industry, staying ahead of emerging trends is crucial for businesses to thrive.
With the start of 2025 just around the corner, and in an era marked by technological advancements, regulatory change and shifting consumer demand, several trends are poised to shape the trajectory of the pharmaceutical market, and in turn packaging and manufacturing.
Here is a comprehensive look into what stakeholders can expect over the next year as we go into 2025.
The rising use of sustainable packaging materials.
Sustainability will continue to take centre stage in pharmaceutical packaging, aligning with the global shift towards eco-conscious practices. There is a critical need for the industry to embrace this trend in 2024 as more people are aligning lifestyle choices with sustainability metrics.
With customers prepared to vote with their euros, we’ll be seeing more brands experiment with environmentally friendly packaging materials in the coming year. Compostable packaging, for example, has been gaining traction.
Despite these advancements, the assessment of true sustainability requires a holistic approach. Manufacturers must consider all stages of manufacturing, including decomposition and waste management of all alternatives claiming greater sustainability.
This starts with materials being selected based on how easily they can be reused or recycled into new products with as little waste as possible, as well as how resource-intensive or carbon-heavy production is. While paper-based packaging ranks favourably among consumers for sustainable promises, for example, it has been accused of exacerbating water loss and climate change.
The growing trend of pharmacogenomics (PGx).
As personalized medicine becomes more prevalent, so too will the need for unique packaging solutions. There will be a heightened need for contract packaging firms such as ourselves to meet the increasingly specific requirements of tailored pharmaceutical packaging.
We’ll also see increasing demand for personalized parenteral products and packaging, including personalized patient information leaflets (PILs). More flexibility and efficiency in supply chain processes will be needed to respond to growing low-volume manufacturing requirements of tailored medicine packaging.
However, the integration of personal and sensitive medical information into personalized packaging necessitates robust security measures. With the intelligent pharmaceutical packaging industry growing rapidly, promising a predicted compound annual growth rate (CAGR) of 9% between 2020 and 2025, innovation and technological advancements in packaging could be the answer to safeguarding personal data.
Examples include scannable QR codes and Near Field Communication (NFC) technology, both of which enable users of smartphones to scan product packaging and be served the relevant information about the medicine to which it is attached.
Watch this space, as part of The Asteria Group it will no doubt be both an interesting and progressive year!
